✨ Unlock Data Exports And Disclosure Access. Start Your 30-Day Free Trial Today →

Samsung Biologics Co Ltd

Common Name
Samsung Biologics
Country
South Korea
Sector
Healthcare
Industry
Biotechnology
Employees
4,770
Ticker
207940
Exchange
KOREA EXCHANGE
Description
Samsung Biologics Co., Ltd. is a key player in the biopharmaceutical manufacturing and services industry. Established as a subsidiary of Samsung Group, it focuses on the development and manufacturing ...

Samsung Biologics's GHG Emissions Data Preview

In 2024, Samsung Biologics completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy) and Scope 3 (indirect emissions across the value chain).

Samsung Biologics has also provided a category-level breakdown for 11 out of 15 Scope 3 emissions categories, offering greater transparency into its value chain emissions.

Metric (tCO2e)202420232022
2021 - 2017
Total Scope 1
0000000
Copy/Paste is a PRO feature.
a
Copy/Paste is a PRO feature.
a
0000000
Total Scope 2
Market-Based
Copy/Paste is a PRO feature.
a
0000000
Copy/Paste is a PRO feature.
a
0000000
Location-Based
Copy/Paste is a PRO feature.
a
0000000
Copy/Paste is a PRO feature.
a
0000000
Unspecified Calculation Method
Copy/Paste is a PRO feature.
0000000
Copy/Paste is a PRO feature.
0000000
Total Scope 3
Copy/Paste is a PRO feature.
a
Copy/Paste is a PRO feature.
a
0000000
0000000
Total Scope 1 Revenue Intensity (tCO2e/$M)
0000000
Copy/Paste is a PRO feature.
a
Copy/Paste is a PRO feature.
a
0000000
Limited Data Preview
You are viewing a limited preview of Samsung Biologics’s GHG emissions dataset. The full dataset, available for download, includes Scope 1, 2, and 3 emissions with detailed category-level breakdowns, historical coverage back to 2019, and revenue-based intensity metrics for each scope.
Access Datasets, Disclosures, and Sources
pro
Remove manual data sourcing from your workflow. Subscribe to Tracenable Pro to get credits for accessing and exporting datasets and disclosures across 8,500+ companies with 10+ years of historical coverage.
Download granular datasets (CSV/XLS)
Access underlying corporate disclosures (PDF)
Trace all values back to their original sources
Formats Included
Excel
CSV
Json
All data fully traceable to original sources
Used by 1,000+ teams in finance, climate, and research
Access this data via API
$curl "https://tracenable.com/api/v1/ghg-emissions/absolute?ticker=207940&reporting_period=2024"

Verified Sources Behind Samsung Biologics’s Greenhouse Gas (GHG) Emissions Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Samsung Biologics’s data sources below and access millions more through our Disclosure Search.

a. Samsung Biologics's ESG Report 2025
b. Samsung Biologics's ESG Report 2023

Insights into Samsung Biologics's Operational Emissions

In 2024, the total operational greenhouse gas (GHG) emissions of Samsung Biologics amounted to 233,709.069 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).a

Compared to 2023, the total operational greenhouse gas (GHG) emissions of Samsung Biologics increased by 6.38%, suggesting that the company faced challenges in reducing its emissions from its core operations.a

Samsung Biologics's Scope 1 Emissions Over Time

201920202021202220232024020 k40 k60 k80 ktCO2e+4%+2%+24%+27%+4%
  • Total Scope 1
  • Year-over-Year Change

What are Samsung Biologics's Scope 1 emissions?

In 2024, the total Scope 1 emissions of Samsung Biologics were 71,971.718 metric tons of CO₂ equivalent (tCO₂e).a

Has Samsung Biologics reduced its Scope 1 emissions over time?

Since 2019, Samsung Biologics's Scope 1 emissions have increased by 73.56%, reflecting a rising long-term trend in Scope 1 emissions over time.ab

Compared to the previous year (2023), Samsung Biologics's Scope 1 emissions increased by 3.91%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations.a

What are Samsung Biologics's Scope 2 emissions?

In 2024, Samsung Biologics reported Scope 2 greenhouse gas (GHG) emissions of 115,827.854 tCO₂e using the market-based method and 161,737.351 tCO₂e using the location-based method.a

Has Samsung Biologics reduced its Scope 2 emissions over time?

Compared to the previous year (2023), Samsung Biologics's Scope 2 emissions (Location-Based) have remained relatively stable, indicating that Samsung Biologics's emissions have plateaued with no significant change in its energy consumption footprint.a

What methodology does Samsung Biologics use for Scope 2 reporting?

In 2024, Samsung Biologics reported its Scope 2 emissions using the market-based method and using the location-based method.a

Samsung Biologics's Scope 2 Emissions Over Time

201920202021202220232024045 k90 k135 k180 ktCO2e
  • Total Scope 2 Location-Based
  • Total Scope 2 Market-Based
  • Total Scope 2 (Unspecified Calculation Method)

Insights into Samsung Biologics's Value Chain Emissions

In 2024, Samsung Biologics reported 448,410.157 metric tons of CO₂ equivalent (tCO₂e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain.a

The 2024 disclosure of Samsung Biologics includes a breakdown across 11 of the 15 Scope 3 categories defined by the GHG Protocol, matching the level of disclosure in 2023, demonstrating consistent Scope 3 emissions reporting coverage year over year.a

Samsung Biologics's Scope 3 Emissions Over Time

202020212022202320240250 k500 k750 k1 MtCO2e+1329%-14%-35%-13%
  • Total Scope 3
  • Year-over-Year Change

What are Samsung Biologics's Scope 3 emissions?

In 2024, Samsung Biologics reported total Scope 3 emissions of 448,410.157 metric tons of CO₂ equivalent (tCO₂e).a

Approximately 91.89% of these emissions originated from upstream activities such as purchased goods and capital goods, while 8.11% came from downstream activities like product use, distribution, and end-of-life treatment.a

Compared to the previous year (2023), Samsung Biologics's Scope 3 emissions decreased by 12.73%, highlighting the company's efforts to lower indirect emissions from its value chain.a

What categories of Scope 3 emissions does Samsung Biologics disclose?

In 2024, Samsung Biologics reported emissions for 11 out of the 15 Scope 3 categories defined by the GHG Protocol.a

This reflects a high level of granularity and transparency in the company's emissions reporting.

What are the main sources of Samsung Biologics's Scope 3 emissions?

In 2024, the largest contributors to Samsung Biologics's Scope 3 emissions were:a

  • Purchased Goods and Services (Cat. 1): 303,852.504 tCO₂e (67.76%)
  • Capital Goods (Cat. 2): 50,200.289 tCO₂e (11.2%)
  • Fuel- and Energy-Related Services (Cat. 3): 36,648.358 tCO₂e (8.17%)

Samsung Biologics's Scope 3 Emissions by Categories

Purchased Goods andServices (Cat. 1)(67.8%)Capital Goods(Cat. 2)(11.2%)Fuel- andEnergy-RelatedServices (Cat. 3)(8.2%)

Insights into Samsung Biologics’s GHG Emissions Intensity Compared to Industry Peers

In 2024, Samsung Biologics reported Scope 1 greenhouse gas (GHG) emissions of 71,971.718 tCO₂e and total revenues of USD 3,099 millions. This translates into an emissions intensity of 23.22 tCO₂e per millions USD.a

Samsung Biologics's Scope 1 Emissions Intensity Compared to Peers

202002,00020,000200,000Scope 1 Emissions (tCO2e)101001,00010,000100,000Revenues (Millions of USD)FLGenmabYear: 2024Scope 1: 534 tCO2eRevenue: $M 3,003Scope 1 Intensity: 0.18 tCO2e/$MIncyteYear: 2024Scope 1: 9,576 tCO2eRevenue: $M 4,241Scope 1 Intensity: 2.26 tCO2e/$MBio-TechneYear: 2023Scope 1: 3,001 tCO2eRevenue: $M 1,137Scope 1 Intensity: 2.64 tCO2e/$MBavarian NordicYear: 2024Scope 1: 4,111 tCO2eRevenue: $M 797Scope 1 Intensity: 5.16 tCO2e/$MFFFortrea HoldingsYear: 2023Scope 1: 864 tCO2eRevenue: $M 3,109Scope 1 Intensity: 0.28 tCO2e/$MInnovent BiologicsYear: 2024Scope 1: 48 tCO2eRevenue: $M 1,409Scope 1 Intensity: 0.03 tCO2e/$MSK BiopharmaceuticalsYear: 2024Scope 1: 414 tCO2eRevenue: $M 373Scope 1 Intensity: 1.11 tCO2e/$MSK BioscienceYear: 2023Scope 1: 5,863 tCO2eRevenue: $M 289Scope 1 Intensity: 20.28 tCO2e/$MHalozyme TherapeuticsYear: 2024Scope 1: 1,348 tCO2eRevenue: $M 1,015Scope 1 Intensity: 1.33 tCO2e/$MLLLigaChem BiosciencesYear: 2023Scope 1: 308 tCO2eRevenue: $M 27Scope 1 Intensity: 11.53 tCO2e/$MHLBYear: 2024Scope 1: 131 tCO2eRevenue: $M 46Scope 1 Intensity: 2.82 tCO2e/$MModernaYear: 2024Scope 1: 13,180 tCO2eRevenue: $M 3,199Scope 1 Intensity: 4.12 tCO2e/$MSarepta TherapeuticsYear: 2023Scope 1: 3,428 tCO2eRevenue: $M 1,243Scope 1 Intensity: 2.76 tCO2e/$MBioconYear: 2025Scope 1: 27,951 tCO2eRevenue: $M 1,762Scope 1 Intensity: 15.87 tCO2e/$MZhifeiYear: 2024Scope 1: 13,576 tCO2eRevenue: $M 3,572Scope 1 Intensity: 3.80 tCO2e/$MCelltrionYear: 2024Scope 1: 27,147 tCO2eRevenue: $M 2,424Scope 1 Intensity: 11.20 tCO2e/$MBiontechYear: 2024Scope 1: 2,405 tCO2eRevenue: $M 3,341Scope 1 Intensity: 0.72 tCO2e/$MCamurusYear: 2024Scope 1: 116 tCO2eRevenue: $M 169Scope 1 Intensity: 0.68 tCO2e/$MAlnylam PharmaceuticalsYear: 2024Scope 1: 3,832 tCO2eRevenue: $M 2,248Scope 1 Intensity: 1.70 tCO2e/$MBeOne MedicinesYear: 2024Scope 1: 3,547 tCO2eRevenue: $M 27,369Scope 1 Intensity: 0.13 tCO2e/$MPharmaron BeijingYear: 2024Scope 1: 34,268 tCO2eRevenue: $M 1,682Scope 1 Intensity: 20.37 tCO2e/$MWuXi Biologics (Cayman)Year: 2024Scope 1: 38,346 tCO2eRevenue: $M 2,779Scope 1 Intensity: 13.80 tCO2e/$MBioMarin PharmaceuticalYear: 2022Scope 1: 14,000 tCO2eRevenue: $M 2,096Scope 1 Intensity: 6.68 tCO2e/$MSamsung BiologicsYear: 2024Scope 1: 71,972 tCO2eRevenue: $M 3,099Scope 1 Intensity: 23.22 tCO2e/$M

How does Samsung Biologics's GHG emissions intensity compare to its peers?

In 2024, Samsung Biologics reported a Scope 1 emissions intensity of 23.22 tCO₂e per millions USD. Compared to the peer group median of 2.76, this places the company above its industry benchmark, indicating it is less carbon-efficient than most competitors.a

Where does Samsung Biologics rank on GHG emissions intensity within its industry?

In 2024, Samsung Biologics ranked 24 out of 23 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD).a

This places Samsung Biologics among the least efficient performers, with one of the highest emissions intensities in its sector.a

Insights into Samsung Biologics's Total Carbon Footprint

In 2024, Samsung Biologics reported a total carbon footprint of 682,119.226 metric tons of CO₂ equivalent (tCO₂e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 7.01% decrease compared to 2023, indicating progress in reducing its overall greenhouse gas output.a

The largest contributor to Samsung Biologics's total carbon footprint was Scope 3 emissions, accounting for 65.74% of the company's total carbon footprint, followed by Scope 2 emissions at 23.71%.a

Want Full Access to Samsung Biologics's GHG Emissions Dataset?
Start 30-Day Free Trial